| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $644K | -18.2% |
| Cost of Revenue | $583K | +25.9% |
| Gross Profit | $61K | -81.2% |
| R&D Expense | $2.9M | -31.0% |
| SG&A Expense | $9.3M | -12.9% |
| Operating Income | -$12.4M | +19.9% |
| Pre-tax Income | -$8.8M | +37.1% |
| Income Tax | $0 | — |
| Net Income | -$8.8M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.2M | -64.4% |
| Accounts Receivable | $117K | +64.8% |
| Inventory | $457K | -22.4% |
| Current Assets | $7.4M | -55.5% |
| Total Assets | $7.7M | -55.5% |
| Current Liabilities | $1.9M | -5.5% |
| Total Liabilities | $5.3M | -41.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.4M | +27.2% |
| Capital Expenditures | $29K | +70.6% |
| Investing Cash Flow | -$29K | -163.6% |
| Financing Cash Flow | $1.1M | -94.0% |
| Free Cash Flow | -$10.4M | +27.1% |
| +37.1% |
| EPS (Basic) | -$14.56 | -1300.0% |
| EPS (Diluted) | -$14.56 | -1300.0% |
| Stockholders' Equity |
| $2.4M |
| -71.2% |